Avax One Technology (AVX) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
31 Mar, 2026Executive summary
Report covers the quarter ended June 30, 2024, with continued focus on Ag-Tech solutions and commercialization of proprietary IP in agriculture and food products.
Commercialization of UN(THINK) Awakened Flour™ and hydroxyl generating devices advanced, with initial sales in North America and Mexico.
Management restructuring included appointment of a new CEO and operational cost reductions.
Financial highlights
Revenue for the six months ended June 30, 2024 was $41,315, all from hydroxyl device sales; no revenue in the prior year period.
Net loss for the six months ended June 30, 2024 was $7.56 million, compared to $4.25 million in the prior year.
Operating expenses decreased 57% year-over-year to $2.48 million for the quarter, driven by lower headcount and reduced M&A spending.
Cash at June 30, 2024 was $2.94 million, down from $3.88 million at December 31, 2023.
Accumulated deficit increased to $52.07 million as of June 30, 2024.
Outlook and guidance
Management expects continued operating losses and will seek additional capital through debt or equity to fund operations and commercialization.
Substantial doubt exists about the ability to continue as a going concern for the next twelve months without new financing.
Plans include expanding product commercialization, new product development, and international distribution agreements.
Latest events from Avax One Technology
- Institutional-grade vehicle offers high-yield Avalanche exposure, fintech M&A, and onchain finance growth.AVX
Investor presentation13 Apr 2026 - Key votes include director elections, auditor ratification, and a reverse split to support Nasdaq listing.AVX
Proxy filing13 Apr 2026 - Avalanche-focused treasury strategy drove Q4 revenue surge and strong 2026 growth outlook.AVX
Q4 202531 Mar 2026 - Acquired a 5 MW Ohio bitcoin mining facility with 900 S19J Pro Antminers for $4.55 million.AVX
Q4 202431 Mar 2026 - Resale of shares by existing investors; no new capital raised; high exposure to Bitcoin volatility.AVX
Registration filing31 Mar 2026 - Major PIPE Transaction and equity plan expansion to reshape board and digital asset strategy.AVX
Proxy filing31 Mar 2026 - Annual meeting seeks approval for director elections, auditor, reverse split, and new equity plan.AVX
Proxy filing31 Mar 2026 - Net loss widened to $13.4M on $41K revenue, with a $4.1M asset impairment and RCS acquisition completed.AVX
Q3 202431 Mar 2026 - Annual meeting seeks approval for director elections, auditor, reverse split, and new equity plan.AVX
Proxy filing31 Mar 2026